Veru Stock News

Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results. TOP Financial Group Limited (

U.S. stocks pared gains toward the end of trading, with the Nasdaq Composite turning lower on Thursday. The Dow traded up 0.21% to 33,380.67 while the NASDAQ fell 0.46% to 12,795.35. The S&P also rose

Gainers Timber Pharmaceuticals, Inc. (NYSE: TMBR) shares rose 63.8% to $0.1769. Timber Pharmaceuticals recently announced closing of $8.0 million public offering. T2 Biosystems, Inc. (NASDAQ: TTOO) s

Investors eagerly wait authorization of Veru's COVID-19 therapy.

Absci Corporation (NASDAQ: ABSI) jumped 38.8% to $5.83 after the company reported a narrower Q2 loss. Veru Inc (NASDAQ: VERU) shares gained 30.5% to $15.36 after the company reported Q3 earnings res

U.S. stocks traded higher midway through trading, following the release of PPI data. The Dow traded up 0.61% to 33,512.58 while the NASDAQ rose 0.19% to 12,878.62. The S&P also rose, gaining, 0.49% to

U.S. stocks traded higher this morning, following the release of PPI data. The Dow traded up 0.66% to 33,530.83 while the NASDAQ rose 0.72% to 12,947.86. The S&P also rose, gaining, 0.66% to 4,238.00.

Investors eagerly wait authorization of Veru's COVID-19 therapy.

Veru Inc. (NASDAQ:VERU ) Q3 2022 Earnings Conference Call August 11, 2022 8:00 AM ET Company Participants Samuel Fisch - Executive Director, IR & Corporate Communications Mitchell Steiner - Chairman,

Veru Inc. (VERU) delivered earnings and revenue surprises of -55.56% and 42.36%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Source: Shutterstock Veru (NASDAQ: VERU ) stock is heading higher on Thursday as investors celebrate positive news in its earnings report for the fiscal third quarter of 2022. However, it's not the ea

--Sabizabulin for COVID-19 Emergency Use Authorization Application Submitted to U.S. FDA in June 2022-- --The UK’s Medicines and Healthcare Products Regulatory Agency Informed the Company that its S

Veru Inc. (VERU) delivered earnings and revenue surprises of -55.56% and 42.36%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Akerna Corp. (KERN) delivered earnings and revenue surprises of -16.67% and 13.80%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Can they continue outperforming the S&P?